Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Expanding Chemical Probe Space: Quality Criteria for Covalent and Degrader Probes
Ingo V. Hartung, Joachim Rudolph, Mary M. Mader, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9297-9312
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update
Laura Hillebrand, Xiaojun Julia Liang, Ricardo Augusto Massarico Serafim, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 7668-7758
Closed Access | Times Cited: 37
DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance
Martin Schröder, Martin Renatus, Xiaoyou Liang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 32
Chemical Proteomic Discovery of Isotype‐Selective Covalent Inhibitors of the RNA Methyltransferase NSUN2
Yongfeng Tao, Jan G. Felber, Zhongyu Zou, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 51
Open Access | Times Cited: 23
Chemoproteomics Identifies State-Dependent and Proteoform-Selective Caspase-2 Inhibitors
José O. Castellón, Samuel Ofori, Nikolas R. Burton, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 22, pp. 14972-14988
Closed Access | Times Cited: 11
Development of Highly Potent and Selective Covalent FGFR4 Inhibitors Based on SNAr Electrophiles
Moritz Schwarz, Maksym Kurkunov, Florian Wittlinger, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6549-6569
Closed Access | Times Cited: 8
Expanding the ligand spaces for E3 ligases for the design of protein degraders
Rahman Shah Zaib Saleem, Martin P. Schwalm, Stefan Knapp
Bioorganic & Medicinal Chemistry (2024) Vol. 105, pp. 117718-117718
Open Access | Times Cited: 7
Chemical tools to expand the ligandable proteome: diversity-oriented synthesis-based photoreactive stereoprobes
Daisuke Ogasawara, David B. Konrad, Zher Yin Tan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 6
Functional Characterization of Pathway Inhibitors for the Ubiquitin-Proteasome System (UPS) as Tool Compounds for CRBN and VHL-Mediated Targeted Protein Degradation
Martin P. Schwalm, Amelie Menge, Lewis Elson, et al.
ACS Chemical Biology (2025) Vol. 20, Iss. 1, pp. 94-104
Open Access
Targeting TAK1: Evolution of inhibitors, challenges, and future directions
Nika Strašek Benedik, Matic Proj, Christian Steinebach, et al.
Pharmacology & Therapeutics (2025), pp. 108810-108810
Open Access
Covalent hits and where to find them
Simon C. C. Lucas, J. Henry Blackwell, Sarah H. Hewitt, et al.
SLAS DISCOVERY (2024) Vol. 29, Iss. 3, pp. 100142-100142
Open Access | Times Cited: 5
Discovery of a cell-active chikungunya virus nsP2 protease inhibitor using a covalent fragment-based screening approach
Eric M. Merten, John D. Sears, Tina M. Leisner, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Degron tagging for rapid protein degradation in mice
Brianda Areli Hernández-Morán, Gillian C.A. Taylor, Álvaro Lorente‐Macías, et al.
Disease Models & Mechanisms (2024) Vol. 17, Iss. 4
Open Access | Times Cited: 4
Covalent Degrader of the Oncogenic Transcription Factor β-Catenin
Flor A. Gowans, Nafsika Forte, J. D. Hatcher, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 24, pp. 16856-16865
Open Access | Times Cited: 4
Delineating cysteine-reactive compound modulation of cellular proteostasis processes
Ashley R. Julio, Flowreen Shikwana, Cindy Truong, et al.
Nature Chemical Biology (2024)
Closed Access | Times Cited: 4
Pervasive aggregation and depletion of host and viral proteins in response to cysteine-reactive electrophilic compounds
Ashley R. Julio, Flowreen Shikwana, Cindy Truong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 9
Which Small Molecule? Selecting Chemical Probes for Use in Cancer Research and Target Validation
Mary M. Mader, Joachim Rudolph, Ingo V. Hartung, et al.
Cancer Discovery (2023) Vol. 13, Iss. 10, pp. 2150-2165
Open Access | Times Cited: 8
tracerDB: a crowdsourced fluorescent tracer database for target engagement analysis
Johannes Dopfer, James D. Vasta, Susanne Müller, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Identification of a cell-active chikungunya virus nsP2 protease inhibitor using a covalent fragment-based screening approach
Eric M. Merten, John D. Sears, Tina M. Leisner, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 42
Closed Access | Times Cited: 2
Chemical tools to expand the ligandable proteome: Diversity-oriented synthesis-based photoreactive stereoprobes
Daisuke Ogasawara, David B. Konrad, Zher Yin Tan, et al.
Cell chemical biology (2024)
Open Access | Times Cited: 2
Protein degraders - from thalidomide to new PROTACs
Takumi Ito
The Journal of Biochemistry (2023) Vol. 175, Iss. 5, pp. 507-519
Open Access | Times Cited: 7
Targeting LC3/GABARAP for degrader development and autophagy modulation
Martin P. Schwalm, Johannes Dopfer, Adarsh Kumar, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 6
The 17th EFMC Short Course on Medicinal Chemistry on Small Molecule Protein Degraders
Alessio Ciulli, Suzanne O’Connor, Chun‐wa Chung, et al.
ChemMedChem (2023) Vol. 18, Iss. 20
Open Access | Times Cited: 6
Structure-Guided Design of a Domain-Selective Bromodomain and Extra Terminal N-Terminal Bromodomain Chemical Probe
Erin K. Bradley, Lucia Fusani, Chun‐wa Chung, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 23, pp. 15728-15749
Open Access | Times Cited: 6
Erastin-like anti-Warburg compounds X1 and X4 are GLS2-selective covalent glutaminase inhibitors
Clea Crane, M Miele, Ranjini Iyengar, et al.
(2024)
Open Access | Times Cited: 1
Structural Fusion of Natural and Synthetic Ligand Features Boosts RXR Agonist Potency
Gustave Adouvi, Felix Nawa, Marco Ballarotto, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 24, pp. 16762-16771
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top